NasdaqGM - Delayed Quote • USD
ADMA Biologics, Inc. (ADMA)
At close: April 25 at 4:00 PM EDT
After hours: April 25 at 6:55 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
8,800.00
8,800.00
-59,508.00
-112,369.00
-102,002.96
Investing Cash Flow
-4,981.00
-4,981.00
-13,911.00
-13,511.00
-12,724.68
Financing Cash Flow
-38,989.00
-38,989.00
108,852.00
121,048.00
143,896.66
End Cash Position
51,352.00
51,352.00
86,522.00
51,089.00
55,921.15
Interest Paid Supplemental Data
18,051.00
18,051.00
13,880.00
11,159.00
10,267.63
Capital Expenditure
-4,981.00
-4,981.00
-13,911.00
-13,511.00
-12,726.68
Issuance of Capital Stock
--
--
64,645.00
121,144.00
131,195.29
Issuance of Debt
135,000.00
135,000.00
151,750.00
--
27,500.00
Repayment of Debt
-158,601.00
-158,601.00
-100,036.00
-34.00
-13,982.07
Free Cash Flow
3,819.00
3,819.00
-73,419.00
-125,880.00
-114,729.64
12/31/2020 - 10/17/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ANNX Annexon, Inc.
4.5900
+3.15%
EYEN Eyenovia, Inc.
0.7113
+21.90%
VNDA Vanda Pharmaceuticals Inc.
4.4800
-1.75%
CDTX Cidara Therapeutics, Inc.
13.00
+5.78%
IOVA Iovance Biotherapeutics, Inc.
11.54
-1.45%
FGEN FibroGen, Inc.
1.0200
+3.63%
PBYI Puma Biotechnology, Inc.
4.8800
+1.04%
CADL Candel Therapeutics, Inc.
6.43
+6.28%
ENTX Entera Bio Ltd.
2.0000
-3.38%
ARDX Ardelyx, Inc.
6.31
-1.87%